CLINICAL_TRIALS
withdrawal
· 2014-06-02
Clinical Trial Update: Phase Analysis and Obstructive CAD on Rubidium PET [Phase 2]
Summary
Phase 2 trial evaluating rubidium PET imaging for obstructive coronary artery disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Coronary Artery Disease | Phase 2 | Status: WITHDRAWN